{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:40:53Z","timestamp":1791222053013,"version":"4.1.0"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1097\/fpc.0b013e32836498f4","type":"journal-article","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T12:29:21Z","timestamp":1375360161000},"page":"498-508","source":"Crossref","is-referenced-by-count":63,"title":["PharmGKB summary"],"prefix":"10.1097","volume":"23","author":[{"given":"Ellen M.","family":"McDonagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Youngster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russ B.","family":"Altman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri E.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R4-7-20210213","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/10520295.2010.515491","article-title":"How Romanowsky stains work and why they remain valuable - including a proposed universal Romanowsky staining mechanism and a rational troubleshooting scheme.","volume":"86","author":"Horobin","year":"2011","journal-title":"Biotech Histochem"},{"key":"R5-7-20210213","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/10520290310001602404","article-title":"The use of dyes in modern biomedicine.","volume":"78","author":"Wainwright","year":"2003","journal-title":"Biotech Histochem"},{"key":"R7-7-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-012-2886-x","article-title":"From methylene blue to chloroquine: a brief review of the development of an antimalarial therapy.","volume":"111","author":"Krafts","year":"2012","journal-title":"Parasitol Res"},{"key":"R9-7-20210213","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-3156.2005.01417.x","article-title":"The phenothiazinium chromophore and the evolution of antimalarial drugs.","volume":"10","author":"Wainwright","year":"2005","journal-title":"Trop Med Int Health"},{"key":"R10-7-20210213","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00002018-200831110-00003","article-title":"Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.","volume":"31","author":"Sweiss","year":"2008","journal-title":"Drug Saf"},{"key":"R11-7-20210213","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00776-009-1431-y","article-title":"Ifosfamide encephalopathy associated with chemotherapy for musculoskeletal sarcomas: incidence, severity, and risk factors.","volume":"15","author":"Tajino","year":"2010","journal-title":"J Orthop Sci"},{"key":"R12-7-20210213","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/pon.1161","article-title":"Ifosfamide neuropsychiatric toxicity in patients with cancer.","volume":"16","author":"Alici-Evcimen","year":"2007","journal-title":"Psychooncology"},{"key":"R13-7-20210213","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1399-6576.1998.tb05173.x","article-title":"Methemoglobinemia induced by methylene blue pertubation during laparoscopy.","volume":"42","author":"Bilgin","year":"1998","journal-title":"Acta Anaesthesiol Scand"},{"key":"R14-7-20210213","first-page":"252","article-title":"Methylene blue-induced hyperbilirubinemia in neonatal glucose-6-phosphate dehydrogenase (G6PD) deficiency.","volume":"9","author":"Gauthier","year":"2000","journal-title":"J Matern Fetal Med"},{"key":"R15-7-20210213","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1096\/fj.07-9610com","article-title":"Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways.","volume":"22","author":"Atamna","year":"2008","journal-title":"FASEB J"},{"key":"R16-7-20210213","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1592\/phco.30.7.702","article-title":"Methylene blue for the treatment of septic shock.","volume":"30","author":"Paciullo","year":"2010","journal-title":"Pharmacotherapy"},{"key":"R18-7-20210213","first-page":"585","article-title":"Methylene blue as an antidote for cyanide and carbon monoxide poisoning.","volume":"43","author":"Moldenhauer Brooks","year":"1936","journal-title":"Sci Mon"},{"key":"R19-7-20210213","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1038\/475S9a","article-title":"Drugs: a tangled web of targets.","volume":"475","author":"Gravitz","year":"2011","journal-title":"Nature"},{"key":"R20-7-20210213","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1750-3639.2010.00430.x","article-title":"Methylene blue reduces a levels and rescues early cognitive deficit by increasing proteasome activity.","volume":"21","author":"Medina","year":"2011","journal-title":"Brain Pathol"},{"key":"R21-7-20210213","first-page":"42","article-title":"Methylene blue mediated photodynamic therapy for resistant plaque psoriasis.","volume":"8","author":"Salah","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"R22-7-20210213","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.antiviral.2005.07.001","article-title":"Methylene blue photoinactivation abolishes West Nile virus infectivity in vivo.","volume":"68","author":"Papin","year":"2005","journal-title":"Antiviral Res"},{"key":"R23-7-20210213","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1089\/pho.2006.24.528","article-title":"New photodynamic therapy protocol to treat AIDS-related Kaposis sarcoma.","volume":"24","author":"Tardivo","year":"2006","journal-title":"Photomed Laser Surg"},{"key":"R24-7-20210213","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2180-9-27","article-title":"In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent.","volume":"9","author":"Zolfaghari","year":"2009","journal-title":"BMC Microbiol"},{"key":"R25-7-20210213","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/jac\/dkr562","article-title":"Photodynamic medicine and infection control.","volume":"67","author":"Wainwright","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"R26-7-20210213","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/SMJ.0b013e318232139f","article-title":"Methemoglobinemia: pathogenesis, diagnosis, and management.","volume":"104","author":"Skold","year":"2011","journal-title":"South Med J"},{"key":"R27-7-20210213","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0196-0644(82)80502-7","article-title":"Methemoglobinemia.","volume":"11","author":"Curry","year":"1982","journal-title":"Ann Emerg Med"},{"key":"R28-7-20210213","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ajh.2830420104","article-title":"Concise review: methemoglobinemia.","volume":"42","author":"Mansouri","year":"1993","journal-title":"Am J Hematol"},{"key":"R29-7-20210213","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00139709-200423030-00004","article-title":"Oxidant stress and haemolysis of the human erythrocyte.","volume":"23","author":"Sivilotti","year":"2004","journal-title":"Toxicol Rev"},{"key":"R30-7-20210213","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0196-0644(99)70167-8","article-title":"Methemoglobinemia: etiology, pharmacology, and clinical management.","volume":"34","author":"Wright","year":"1999","journal-title":"Ann Emerg Med"},{"key":"R32-7-20210213","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2141.2005.05404.x","article-title":"Drug-induced haemolysis and methaemoglobinaemia in glucose 6-phosphate dehydrogenase deficiency.","volume":"129","author":"Dalal","year":"2005","journal-title":"Br J Haematol"},{"key":"R33-7-20210213","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-75-1-83","article-title":"Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency.","volume":"75","author":"Rosen","year":"1971","journal-title":"Ann Intern Med"},{"key":"R34-7-20210213","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/(SICI)1098-1101(1998)13:1<28::AID-JCA6>3.0.CO;2-B","article-title":"Treatment of high-risk, refractory acquired methemoglobinemia with automated red blood cell exchange.","volume":"13","author":"Golden","year":"1998","journal-title":"J Clin Apher"},{"key":"R35-7-20210213","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/0310057X0703500222","article-title":"Aniline-induced methaemoglobinaemia in a glucose-6-phosphate dehydrogenase enzyme deficient patient.","volume":"35","author":"Mullick","year":"2007","journal-title":"Anaesth Intensive Care"},{"key":"R36-7-20210213","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1460-9592.2004.01420.x","article-title":"Postoperative methemoglobinemia with associated G-6-P-D deficiency in infant cardiac surgery - enigmas in diagnosis and management.","volume":"15","author":"Maddali","year":"2005","journal-title":"Paediatr Anaesth"},{"key":"R37-7-20210213","first-page":"321","article-title":"Prolonged hemolysis and methemoglobinemia following organic copper fungicide ingestion.","volume":"46","author":"Yang","year":"2004","journal-title":"Vet Hum Toxicol"},{"key":"R40-7-20210213","first-page":"659","article-title":"Metoclopramide-induced methemoglobinemia in a patient with co-existing deficiency of glucose-6-phosphate dehydrogenase and NADH-cytochrome b5 reductase: failure of methylene blue treatment.","volume":"86","author":"Karadsheh","year":"2001","journal-title":"Haematologica"},{"key":"R41-7-20210213","first-page":"19","article-title":"Hemolytic anemia after methylene blue therapy for aniline-induced methemoglobinemia.","volume":"44","author":"Liao","year":"2002","journal-title":"Vet Hum Toxicol"},{"key":"R44-7-20210213","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-82-6-810_1","article-title":"Letter: ascorbic acid-induced hemolysis in G-6-PD deficiency.","volume":"82","author":"Campbell","year":"1975","journal-title":"Ann Intern Med"},{"key":"R45-7-20210213","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/0140-6736(90)92317-B","article-title":"Ascorbic-acid-induced haemolysis in G-6-PD deficiency.","volume":"336","author":"Mehta","year":"1990","journal-title":"Lancet"},{"key":"R46-7-20210213","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1182\/blood.V84.11.3613.bloodjournal84113613","article-title":"G6PD deficiency.","volume":"84","author":"Beutler","year":"1994","journal-title":"Blood"},{"key":"R48-7-20210213","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bcmd.2008.12.005","article-title":"The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis.","volume":"42","author":"Nkhoma","year":"2009","journal-title":"Blood Cells Mol Dis"},{"key":"R49-7-20210213","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1073\/pnas.71.9.3584","article-title":"Intracellular restraint: a new basis for the limitation in response to oxidative stress in human erythrocytes containing low-activity variants of glucose-6-phosphate dehydrogenase.","volume":"71","author":"Gaetani","year":"1974","journal-title":"Proc Natl Acad Sci USA"},{"key":"R51-7-20210213","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/FPC.0b013e32834eb313","article-title":"PharmGKB summary: very important pharmacogene information for G6PD.","volume":"22","author":"McDonagh","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"R52-7-20210213","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bcmd.2012.01.001","article-title":"Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the old and update of the new mutations.","volume":"48","author":"Minucci","year":"2012","journal-title":"Blood Cells Mol Dis"},{"key":"R54-7-20210213","first-page":"243","article-title":"Human glucose-6-phosphate dehydrogenase variants.","volume":"45","author":"Yoshida","year":"1971","journal-title":"Bull World Health Organ"},{"key":"R55-7-20210213","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","article-title":"Glucose-6-phosphate dehydrogenase deficiency.","volume":"371","author":"Cappellini","year":"2008","journal-title":"Lancet"},{"key":"R56-7-20210213","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1345\/aph.1G272","article-title":"Hemolysis and methemoglobinemia secondary to rasburicase administration.","volume":"39","author":"Browning","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R57-7-20210213","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molmed.2011.01.014","article-title":"Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase.","volume":"17","author":"Perl","year":"2011","journal-title":"Trends Mol Med"},{"key":"R58-7-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/jbiol63","article-title":"Metabolic reconfiguration is a regulated response to oxidative stress.","volume":"7","author":"Grant","year":"2008","journal-title":"J Biol"},{"key":"R59-7-20210213","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1742-4658.2007.05685.x","article-title":"Simulation study of methemoglobin reduction in erythrocytes. Differential contributions of two pathways to tolerance to oxidative stress.","volume":"274","author":"Kinoshita","year":"2007","journal-title":"FEBS J"},{"key":"R60-7-20210213","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1172\/JCI103936","article-title":"Alterations in metabolic energetics and cation transport during aging of red cells.","volume":"38","author":"Bernstein","year":"1959","journal-title":"J Clin Invest"},{"key":"R62-7-20210213","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/187152910791292547","article-title":"Discussion on pharmacogenetic interaction in G6PD deficiency and methods to identify potential hemolytic drugs.","volume":"10","author":"Manganelli","year":"2010","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"R63-7-20210213","first-page":"141","article-title":"Metabolic genes in cancer: their roles in tumor progression and clinical implications.","volume":"1805","author":"Furuta","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"R64-7-20210213","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/08820139509062760","article-title":"The Ernest Witebsky memorial lecture. Red but not dead: not a hapless sac of hemoglobin.","volume":"24","author":"Greenwalt","year":"1995","journal-title":"Immunol Invest"},{"key":"R65-7-20210213","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1002\/j.1460-2075.1995.tb00205.x","article-title":"Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress.","volume":"14","author":"Pandolfi","year":"1995","journal-title":"EMBO J"},{"key":"R66-7-20210213","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/199704a0","article-title":"Hexokinase activity as a function of age of the human erythrocyte.","volume":"199","author":"Brewer","year":"1963","journal-title":"Nature"},{"key":"R68-7-20210213","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2165\/00003495-200666040-00008","article-title":"Rasburicase: a review of its use in the management of anticancer therapy-induced hyperuricemia.","volume":"66","author":"Oldfield","year":"2006","journal-title":"Drugs"},{"key":"R70-7-20210213","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.blre.2007.05.002","article-title":"G6PD deficiency: the genotype-phenotype association.","volume":"21","author":"Mason","year":"2007","journal-title":"Blood Rev"},{"key":"R71-7-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3460001","article-title":"Thioredoxin reductase.","volume":"346","author":"Mustacich","year":"2000","journal-title":"Biochem J"},{"key":"R72-7-20210213","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1089\/ars.2008.2081","article-title":"Peroxiredoxin 2 and peroxide metabolism in the erythrocyte.","volume":"10","author":"Low","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"R74-7-20210213","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0891-5849(98)00060-4","article-title":"Enzyme-dependent ascorbate recycling in human erythrocytes: role of thioredoxin reductase.","volume":"25","author":"Mendiratta","year":"1998","journal-title":"Free Radic Biol Med"},{"key":"R75-7-20210213","doi-asserted-by":"crossref","first-page":"d1","DOI":"10.2741\/A262","article-title":"Ascorbate function and metabolism in the human erythrocyte.","volume":"3","author":"May","year":"1998","journal-title":"Front Biosci"},{"key":"R76-7-20210213","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-4165(01)00188-X","article-title":"Mechanisms of ascorbic acid recycling in human erythrocytes.","volume":"1528","author":"May","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"R77-7-20210213","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tibs.2006.11.003","article-title":"Mammalian catalase: a venerable enzyme with new mysteries.","volume":"32","author":"Kirkman","year":"2007","journal-title":"Trends Biochem Sci"},{"key":"R78-7-20210213","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.abb.2012.04.004","article-title":"The reaction mechanisms of heme catalases: an atomistic view by ab initio molecular dynamics.","volume":"525","author":"Alfonso-Prieto","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"R79-7-20210213","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0021-9258(19)75835-9","article-title":"The function of catalase-bound NADPH.","volume":"262","author":"Kirkman","year":"1987","journal-title":"J Biol Chem"},{"key":"R80-7-20210213","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1182\/blood.V88.3.1084.1084","article-title":"Active involvement of catalase during hemolytic crises of favism.","volume":"88","author":"Gaetani","year":"1996","journal-title":"Blood"},{"key":"R81-7-20210213","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJM199801223380407","article-title":"Respiratory function of hemoglobin.","volume":"338","author":"Hsia","year":"1998","journal-title":"N Engl J Med"},{"key":"R82-7-20210213","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2141.2008.07017.x","article-title":"Recessive congenital methaemoglobinaemia: cytochrome b(5) reductase deficiency.","volume":"141","author":"Percy","year":"2008","journal-title":"Br J Haematol"},{"key":"R83-7-20210213","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.biocel.2005.02.001","article-title":"Investigation of methaemoglobin reduction by extracellular NADH in mammalian erythrocytes.","volume":"37","author":"Kennett","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"R85-7-20210213","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0006-291X(77)91683-7","article-title":"NADPH-flavin reductase in human erythrocytes and the reduction of methemoglobin through flavin by the enzyme.","volume":"76","author":"Yubisui","year":"1977","journal-title":"Biochem Biophys Res Commun"},{"key":"R86-7-20210213","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/oxfordjournals.jbchem.a132915","article-title":"Reduction of methemoglobin through flavin at the physiological concentration by NADPH-flavin reductase of human erythrocytes.","volume":"87","author":"Yubisui","year":"1980","journal-title":"J Biochem"},{"key":"R89-7-20210213","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood.V22.3.323.323","article-title":"Methemoglobin reduction. Studies of the interaction between cell populations and of the role of methylene blue.","volume":"22","author":"Beutler","year":"1963","journal-title":"Blood"},{"key":"R90-7-20210213","first-page":"633","article-title":"Methaemoglobin reduction test: a new, simple, in vitro test for identifying primaquine-sensitivity.","volume":"22","author":"Brewer","year":"1960","journal-title":"Bull World Health Organ"},{"key":"R91-7-20210213","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/jama.1962.03050180032008","article-title":"The methemoglobin reduction test for primaquine-type sensitivity of erythrocytes. A simplified procedure for detecting a specific hypersusceptibility to drug hemolysis.","volume":"180","author":"Brewer","year":"1962","journal-title":"JAMA"},{"key":"R92-7-20210213","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2344\/0003-3006-56.3.86","article-title":"Perioperative management of the glucose-6-phosphate dehydrogenase deficient patient: a review of literature.","volume":"56","author":"Elyassi","year":"2009","journal-title":"Anesth Prog"},{"key":"R95-7-20210213","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/00003246-200004000-00008","article-title":"Comparison of methylene blue, riboflavin, and N-acetylcysteine for the reduction of nitric oxide-induced methemoglobinemia.","volume":"28","author":"Dotsch","year":"2000","journal-title":"Crit Care Med"},{"key":"R100-7-20210213","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1182\/blood-2012-03-416032","article-title":"Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone.","volume":"120","author":"Pamba","year":"2012","journal-title":"Blood"},{"key":"R102-7-20210213","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0304-4165(78)90329-X","article-title":"Effects of hemolysate concentration, ionic strength and cytochrome b5 concentration on the rate of methemoglobin reduction in hemolysates of human erythrocytes.","volume":"544","author":"Sannes","year":"1978","journal-title":"Biochim Biophys Acta"},{"key":"R103-7-20210213","first-page":"703","article-title":"Dapsone-induced methemoglobinemia and hemolysis in the presence of familial hemoglobinopathy Hasharon and familial methemoglobin reductase deficiency.","volume":"17","author":"Ganer","year":"1981","journal-title":"Isr J Med Sci"},{"key":"R104-7-20210213","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF00201829","article-title":"Acatalasemia.","volume":"86","author":"Ogata","year":"1991","journal-title":"Hum Genet"},{"key":"R105-7-20210213","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/jmg.20.4.307","article-title":"Phenazopyridine induced methaemoglobinaemia associated with decreased activity of erythrocyte cytochrome b5 reductase.","volume":"20","author":"Daly","year":"1983","journal-title":"J Med Genet"},{"key":"R106-7-20210213","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM196811212792102","article-title":"Methemoglobinemia provoked by malarial chemoprophylaxis in Vietnam.","volume":"279","author":"Cohen","year":"1968","journal-title":"N Engl J Med"},{"key":"R108-7-20210213","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1007\/BF01946415","article-title":"NADH-methemoglobin reductase activity in the erythrocytes of newborn and adult mammals.","volume":"42","author":"Lo","year":"1986","journal-title":"Experientia"},{"key":"R109-7-20210213","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0006-291X(88)81103-3","article-title":"Role of hexokinase in the regulation of erythrocyte hexose monophosphate pathway under oxidative stress.","volume":"155","author":"Magnani","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"R110-7-20210213","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/jcp.52.4.241","article-title":"The molecular basis of disorders of red cell enzymes.","volume":"52","author":"McMullin","year":"1999","journal-title":"J Clin Pathol"},{"key":"R111-7-20210213","first-page":"760","article-title":"TPNH-methemoglobin reductase deficiency: a new red-cell enzyme defect.","volume":"70","author":"Sass","year":"1967","journal-title":"J Lab Clin Med"},{"key":"R112-7-20210213","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/emj.12.2.138","article-title":"Extreme methaemoglobinaemia secondary to recreational use of amyl nitrite.","volume":"12","author":"Edwards","year":"1995","journal-title":"J Accid Emerg Med"},{"key":"R113-7-20210213","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/01.mjt.0000208876.69103.c7","article-title":"Methemoglobinemia-induced cardio-respiratory failure secondary to topical anesthesia.","volume":"13","author":"Saha","year":"2006","journal-title":"Am J Ther"},{"key":"R114-7-20210213","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0929-693X(96)81305-4","article-title":"Pulse oximetry and methemoglobinemia.","volume":"3","author":"Moretti","year":"1996","journal-title":"Arch Pediatr"},{"key":"R115-7-20210213","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/1078155211429385","article-title":"Methemoglobinemia induced by rasburicase in a pediatric patient: a case report and literature review.","volume":"18","author":"Ng","year":"2011","journal-title":"J Oncol Pharm Pract"},{"key":"R116-7-20210213","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ajh.23182","article-title":"Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase.","volume":"88","author":"Sonbol","year":"2012","journal-title":"Am J Hematol"},{"key":"R117-7-20210213","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/pbc.21193","article-title":"Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphomaleukemia.","volume":"50","author":"Borinstein","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R118-7-20210213","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/cncr.11612","article-title":"Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study.","volume":"98","author":"Bosly","year":"2003","journal-title":"Cancer"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0b013e32836498f4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T21:42:33Z","timestamp":1715809353000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201309000-00007"}},"subtitle":["methylene blue pathway"],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":89,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e32836498f4","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}